A risk-characterization framework for decision-making at the Food and Drug Administration
By: Committee on Ranking FDA Product Categories Based on Health Consequences Phase II, Board on Environmental Studies and Toxicology, Division on Earth and Life Studies, National Research Council, Institute of Medicine
Contributors: National Research Council (U.S.)
Publisher: National Academies Press
Published: 2011
Place of publication: Washington, D.C
Language: eng
Number of pages: 192
ISBN-13: 9780309212809
Subjects: Risk assessment; Product safety; United States; Case studies; Decision making; United States. Food and Drug Administration
Notes: "National Research Council of the National Academies."

Includes bibliographical references.